Exploiting histone deacetylases for cancer therapy: from hematological malignancies to solid tumors

被引：13
作者：
Huang, Min [1 ]
Geng, Meiyu [1 ]
机构：
[1] Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res, Shanghai 201203, Peoples R China
来源：
SCIENCE CHINA-LIFE SCIENCES | 2017年 / 60卷 / 01期
关键词：
INHIBITORS;
D O I：
10.1007/s11427-016-0300-y
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
[No abstract available]
引用
收藏
页码：94 / 97
页数：4
相关论文
共 14 条
[1]   Exploiting the Epigenome to Control Cancer-Promoting Gene-Expression Programs [J].
Brien, Gerard L. ;
Valerio, Daria G. ;
Armstrong, Scott A. .
CANCER CELL, 2016, 29 (04) :464-476
[2]   Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders [J].
Falkenberg, Katrina J. ;
Johnstone, Ricky W. .
NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (09) :673-691
[3]   Lessons from the Cancer Genome [J].
Garraway, Levi A. ;
Lander, Eric S. .
CELL, 2013, 153 (01) :17-37
[4]   Translating the histone code [J].
Jenuwein, T ;
Allis, CD .
SCIENCE, 2001, 293 (5532) :1074-1080
[5]   FDA approval summary: Vorinostat for treatment of advanced primary cutaneous T-cell lymphoma [J].
Mann, Bhupinder S. ;
Johnson, John R. ;
Cohen, Martin H. ;
Justice, Robert ;
Pazdur, Richard .
ONCOLOGIST, 2007, 12 (10) :1247-1252
[6]   Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma [J].
Mazur, Pawel K. ;
Herner, Alexander ;
Mello, Stephano S. ;
Wirth, Matthias ;
Hausmann, Simone ;
Sanchez-Rivera, Francisco J. ;
Lofgren, Shane M. ;
Kuschma, Timo ;
Hahn, Stephan A. ;
Vangala, Deepak ;
Trajkovic-Arsic, Marija ;
Gupta, Aayush ;
Heid, Irina ;
Noel, Peter B. ;
Braren, Rickmer ;
Erkan, Mert ;
Kleeff, Joerg ;
Sipos, Bence ;
Sayles, Leanne C. ;
Heikenwalder, Mathias ;
Hessmann, Elisabeth ;
Ellenrieder, Volker ;
Esposito, Irene ;
Jacks, Tyler ;
Bradner, James E. ;
Khatri, Purvesh ;
Sweet-Cordero, E. Alejandro ;
Attardi, Laura D. ;
Schmid, Roland M. ;
Schneider, Guenter ;
Sage, Julien ;
Siveke, Jens T. .
NATURE MEDICINE, 2015, 21 (10) :1163-+
[7]   Histone deacetylases and epigenetic therapies of hematological malignancies [J].
Mercurio, Ciro ;
Minucci, Saverio ;
Pelicci, Pier Giuseppe .
PHARMACOLOGICAL RESEARCH, 2010, 62 (01) :18-34
[8]   Essential Role of DNA Methyltransferase 1-mediated Transcription of Insulin-like Growth Factor 2 in Resistance to Histone Deacetylase Inhibitors [J].
Min, Hye-Young ;
Lee, Su-Chan ;
Woo, Jong Kyu ;
Jung, Hyun Jin ;
Park, Kwan Hee ;
Jeong, Hae Min ;
Hyun, Seung Yeob ;
Cho, Jaebeom ;
Lee, Wooin ;
Park, Ji Eun ;
Kwon, So Jung ;
Lee, Hyo-Jong ;
Ni, Xiao ;
Shin, Young Kee ;
Johnson, Faye M. ;
Duvic, Madeleine ;
Lee, Ho-Young .
CLINICAL CANCER RESEARCH, 2017, 23 (05) :1299-1311
[9]   Histone modifications: signalling receptors and potential elements of a heritable epigenetic code [J].
Nightingale, KP ;
O'Neill, LP ;
Turner, BM .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2006, 16 (02) :125-136
[10]   HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven Medulloblastoma [J].
Pei, Yanxin ;
Liu, Kun-Wei ;
Wang, Jun ;
Garancher, Alexandra ;
Tao, Ran ;
Esparza, Lourdes A. ;
Maier, Donna L. ;
Udaka, Yoko T. ;
Murad, Najiba ;
Morrissy, Sorana ;
Seker-Cin, Huriye ;
Brabetz, Sebastian ;
Qi, Lin ;
Kogiso, Mari ;
Schubert, Simone ;
Olson, James M. ;
Cho, Yoon-Jae ;
Li, Xiao-Nan ;
Crawford, John R. ;
Levy, Michael L. ;
Kool, Marcel ;
Pfister, Stefan M. ;
Taylor, Michael D. ;
Wechsler-Reya, Robert J. .
CANCER CELL, 2016, 29 (03) :311-323
12